{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:36:44Z","timestamp":1761100604882},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2003.0232","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"653-674","source":"Crossref","is-referenced-by-count":13,"title":["Stem cell transplantation in adult ALL patients"],"prefix":"10.1053","volume":"15","author":[{"given":"I","family":"Avivi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H","family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2003.0232_RF1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults","volume":"71","author":"Hoelzer","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF2","first-page":"481a","article-title":"Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): results from the International ALL Trial (MRC UKALL XII\/ECOG E2993)","volume":"98","author":"Rowe","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.1983.1.8.462","article-title":"Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols","volume":"1","author":"Schauer","year":"1983","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1985.tb07364.x","article-title":"Acute lymphoblastic leukaemia in adults: results of a \u2018total therapy\u2019 program in 47 patients over 15 years old","volume":"59","author":"Sanchez-Fayos","year":"1985","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF5","first-page":"2051","article-title":"Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period","volume":"73","author":"Marcus","year":"1989","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF7","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1988.6.6.1014","article-title":"A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia. The Memorial Hospital experience since 1969","volume":"6","author":"Gaynor","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V67.2.415.415","article-title":"Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia","volume":"67","author":"Bloomfield","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.V73.1.57.57","article-title":"Treatment of acute lymphoblastic leukemia in adults with intensive induction consolidation and maintenance chemotherapy","volume":"73","author":"Hussein","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF11","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.V73.8.2051.2051","article-title":"Acute lymphoblastic leukemia: recent advances in biology and therapy","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.20.4.1094","article-title":"Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia","volume":"20","author":"Mortuza","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF13","first-page":"453","article-title":"Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival","volume":"7","author":"Doney","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2003.0232_RF15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2002.03403.x","article-title":"Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B-lineage acute lymphoblastic leukaemia in first or second remission","volume":"117","author":"Lee","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.1986.tb07585.x","article-title":"Prediction and prevention of relapse of acute lymphoblastic leukemia after bone marrow transplantation","volume":"64","author":"Barrett","year":"1986","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF17","first-page":"1","article-title":"Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia","volume":"15","author":"Campana","year":"2002","journal-title":"Bailli\u00e8re's Clinical Haematology"},{"key":"10.1053\/beha.2003.0232_RF18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2014Childhood Leukemia Cooperative Group","volume":"339","author":"Cave","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2003.0232_RF19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2003.0232_RF20","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood.V87.12.5251.bloodjournal87125251","article-title":"Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia","volume":"87","author":"Brisco","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF21","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V92.11.4072","article-title":"Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia","volume":"92","author":"Knechtli","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM197406202902501","article-title":"Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins","volume":"290","author":"Fefer","year":"1974","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2003.0232_RF23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF24","first-page":"3494","article-title":"Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice","volume":"37","author":"Chester","year":"1977","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2003.0232_RF25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF26","first-page":"S15","article-title":"Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)","volume":"11","author":"Appelbaum","year":"1997","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/1097-0142(19821015)50:8<1449::AID-CNCR2820500802>3.0.CO;2-P","article-title":"The use and potential of bone marrow allograft and whole-body irradiation in the treatment of leukemia","volume":"50","author":"Thomas","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/beha.2003.0232_RF28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1983.tb02169.x","article-title":"Fractionated total body irradiation in marrow transplantation for leukaemia","volume":"55","author":"Vitale","year":"1983","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","article-title":"Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen","volume":"70","author":"Tutschka","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF30","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","article-title":"A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study","volume":"81","author":"Blume","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia","volume":"18","author":"Davies","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF32","first-page":"7","article-title":"Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission","volume":"5","author":"Blaise","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF33","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","article-title":"Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute lymphoblastic leukemia","volume":"12","author":"Sebban","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0360-3016(00)01491-7","article-title":"Total body irradiation before allogeneic bone marrow transplantation: is more dose better?","volume":"49","author":"Bieri","year":"2001","journal-title":"International Journal of Radiation Oncology Biology and Physics"},{"key":"10.1053\/beha.2003.0232_RF35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007890-198703000-00014","article-title":"Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission","volume":"43","author":"Blume","year":"1987","journal-title":"Transplantation"},{"key":"10.1053\/beha.2003.0232_RF36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1988.6.2.227","article-title":"Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission","volume":"6","author":"Vernant","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood.V74.2.862.862","article-title":"Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival","volume":"74","author":"Barrett","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF38","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V78.8.1923.1923","article-title":"Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission","volume":"78","author":"Chao","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF39","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF40","first-page":"767","article-title":"Role of allogeneic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma in first remission","volume":"14","author":"de Witte","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-115-1-13","article-title":"Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission","volume":"115","author":"Horowitz","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2003.0232_RF42","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","article-title":"Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for adult acute lymphoblastic leukemia","volume":"11","author":"Fiere","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","article-title":"Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF44","first-page":"54a","article-title":"Comparison of allogeneic transplantation, autologous transplantation and chemotherapy as post induction treatment in adult acute lymphoblastic (ALL) (LALA87 protocol)","volume":"17","author":"Fiere","year":"1998","journal-title":"Proceedings of the American Society of Clinics"},{"key":"10.1053\/beha.2003.0232_RF45","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0889-8588(05)70190-8","article-title":"Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87","volume":"14","author":"Thiebaut","year":"2000","journal-title":"Hematology and Oncology Clinics of North Amercia"},{"key":"10.1053\/beha.2003.0232_RF46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1701316","article-title":"Chemotherapy versus HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission","volume":"22","author":"Oh","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF47","first-page":"5234","article-title":"Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia","volume":"47","author":"Paciucci","year":"1987","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2003.0232_RF48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/1097-0142(19920201)69:3<709::AID-CNCR2820690318>3.0.CO;2-G","article-title":"Treatment of relapsed or refractory adult acute lymphocytic leukemia","volume":"69","author":"Freund","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/beha.2003.0232_RF49","first-page":"S28","article-title":"Treatment of adult patients with relapsed or refractory acute lymphoblastic leukaemia (ALL)","volume":"11","author":"Weiss","year":"1997","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajh.2830450413","article-title":"Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults","volume":"45","author":"Welborn","year":"1994","journal-title":"Amercian Journal of Hematology"},{"key":"10.1053\/beha.2003.0232_RF51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(87)92809-1","article-title":"Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission","volume":"i","author":"Herzig","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/beha.2003.0232_RF52","first-page":"196","article-title":"Progress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980\u2019s: a report from the IBMTR. The International Bone Marrow Transplant Registry","volume":"6","author":"Bortin","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/beha.2003.0232_RF53","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","article-title":"Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy","volume":"86","author":"Thomas","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/beha.2003.0232_RF54","first-page":"S18","article-title":"The role of allogeneic bone marrow transplantation in the treatment of high-risk acute lymphocytic leukemia in adults","volume":"11","author":"Forman","year":"1997","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198708203170801","article-title":"Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia","volume":"317","author":"Kersey","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2003.0232_RF56","first-page":"917","article-title":"Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study","volume":"17","author":"Fleming","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/02841868809093588","article-title":"Allogeneic bone marrow transplantation in leukemia","volume":"27","author":"Gratwohl","year":"1988","journal-title":"Acta Oncologica"},{"key":"10.1053\/beha.2003.0232_RF58","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.1990.8.5.820","article-title":"Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia","volume":"8","author":"Wingard","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF59","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.bloodjournal8041090","article-title":"Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy","volume":"80","author":"Biggs","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF60","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.1991.9.9.1570","article-title":"Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia","volume":"9","author":"Forman","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7326\/0003-4819-123-6-199509150-00006","article-title":"Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukaemia Working Committee","volume":"123","author":"Zhang","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2003.0232_RF62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2003.0232_RF63","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group For Blood And Marrow Transplantation (EBMT)","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF64","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.1998.16.3.931","article-title":"Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia","volume":"16","author":"Marks","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.bmt.1702162","article-title":"Pediatric marrow transplantation for acute leukemia using unrelated donors and T-replete or -depleted grafts: a case-matched analysis","volume":"25","author":"Vettenranta","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF66","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-02-0400","article-title":"Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in acute lymphoblastic leukemia","author":"Martino","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF68","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF69","first-page":"669a","article-title":"Full haplotype mismatched transplant in high risk acute leukemia patients","volume":"98","author":"Aversa","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF70","first-page":"413a","article-title":"Autologous versus allogeneic unrelated donor leukemia","volume":"96","author":"Wiesdorf","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF71","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","article-title":"Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program","volume":"96","author":"Davies","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF72","first-page":"35","article-title":"Bone marrow donors worldwide","volume":"11","author":"Oudshoorn","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF73","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.1987.5.9.1348","article-title":"Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease","volume":"5","author":"Weisdorf","year":"1987","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1702706","article-title":"Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia","volume":"27","author":"Jandula","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF75","first-page":"105a","article-title":"Antitumour activity of calicheamicin Q, doxorubicin and anti-CD19 immunoconjugates in a human pre-B ALL cell line","volume":"98","author":"Jendreyko","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF76","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.leu.2402203","article-title":"Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions","volume":"5","author":"Schaap","year":"2001","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/bbmt.1998.v4.pm9763110","article-title":"CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy","volume":"4","author":"Jensen","year":"1998","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF78","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1083-8791(00)70024-3","article-title":"Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"6","author":"Snyder","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.1988.tb02488.x","article-title":"Relapse after allogeneic bone marrow transplantation for acute leukemia: a survey by the E.B.M.T. of 117 cases","volume":"70","author":"Frassoni","year":"1988","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1200\/JCO.1989.7.1.50","article-title":"Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy","volume":"7","author":"Mortimer","year":"1989","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF81","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2001.19.16.3675","article-title":"Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation","volume":"19","author":"Bosi","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.bmt.1700680","article-title":"Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes","volume":"19","author":"Kishi","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF83","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2003.0232_RF84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2002.3311a.x","article-title":"Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation","volume":"116","author":"Sanchez","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2003.0232_RF85","first-page":"196","article-title":"Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance","volume":"5","author":"Secker-Walker","year":"1991","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/306239a0","article-title":"Localization of the c-ab1 oncogene adjacent to a translocation breaks point in chronic myelocytic leukemia","volume":"306","author":"Heisterkamp","year":"1983","journal-title":"Nature"},{"key":"10.1053\/beha.2003.0232_RF87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V70.2.587.587","article-title":"Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"70","author":"Forman","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF88","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V79.11.3067.3067","article-title":"Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"79","author":"Barrett","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF89","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood.V85.11.3353.bloodjournal85113353","article-title":"Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"85","author":"Chao","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF90","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/sj.leu.2401589","article-title":"Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission","volume":"13","author":"Snyder","year":"1999","journal-title":"Leukaemia"},{"key":"10.1053\/beha.2003.0232_RF91","first-page":"856a","article-title":"Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Results from the International ALL Trial (MRC UKALLXII\/ECOG E2993)","volume":"98","author":"Goldstone","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF92","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","article-title":"Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome","volume":"97","author":"Cornelissen","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF93","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","article-title":"An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity","volume":"37","author":"Konopka","year":"1984","journal-title":"Cell"},{"key":"10.1053\/beha.2003.0232_RF94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0092-8674(87)90007-9","article-title":"Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia","volume":"51","author":"Hermans","year":"1987","journal-title":"Cell"},{"key":"10.1053\/beha.2003.0232_RF95","first-page":"4a","article-title":"Activity of an ABL specific tyrosine kinase inhibitor in patients with BCR-ABL positive acute leukemia, including chronic myelogenous leukemia in blast crisis","volume":"19","author":"Talpaz","year":"2000","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1053\/beha.2003.0232_RF96","first-page":"828a","article-title":"A Phase 12 study to determine the safety and anti-leukemic effects of STI571 in adult patients with Philadelphia chromosome positive acute leukemia","volume":"96","author":"Ottmann","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2003.0232_RF97","first-page":"3906","article-title":"Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor","volume":"5","author":"Uckun","year":"1999","journal-title":"Clinical Cancer Research"},{"key":"10.1053\/beha.2003.0232_RF98","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.leu.2401812","article-title":"Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1\/CIP1, and induction of apoptosis are independent markers of proteasome inhibition","volume":"14","author":"An","year":"2001","journal-title":"Leukemia"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692603902325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692603902325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:49:38Z","timestamp":1584474578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692603902325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692603902325"],"URL":"https:\/\/doi.org\/10.1053\/beha.2003.0232","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}